Compare APGE & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | HHH |
|---|---|---|
| Founded | 2022 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 3.8B |
| IPO Year | 2023 | 2023 |
| Metric | APGE | HHH |
|---|---|---|
| Price | $134.14 | $64.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $109.67 | $90.00 |
| AVG Volume (30 Days) | ★ 1.2M | 323.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $1,474,892,000.00 |
| Revenue This Year | N/A | $14.04 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $463.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.34 | $61.01 |
| 52 Week High | $134.46 | $91.07 |
| Indicator | APGE | HHH |
|---|---|---|
| Relative Strength Index (RSI) | 79.86 | 34.04 |
| Support Level | $80.52 | $61.79 |
| Resistance Level | N/A | $65.99 |
| Average True Range (ATR) | 0.27 | 1.61 |
| MACD | -1.62 | -0.70 |
| Stochastic Oscillator | 70.00 | 1.79 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.